123 related articles for article (PubMed ID: 16528288)
1. Mechanisms of disease: angiogenesis in urologic malignancies.
Charlesworth PJ; Harris AL
Nat Clin Pract Urol; 2006 Mar; 3(3):157-69. PubMed ID: 16528288
[TBL] [Abstract][Full Text] [Related]
2. Targeting vasculature in urologic tumors: mechanistic and therapeutic significance.
Sakamoto S; Ryan AJ; Kyprianou N
J Cell Biochem; 2008 Feb; 103(3):691-708. PubMed ID: 17668426
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis of prostate cancer and antiangiogenic therapy.
Uehara H
J Med Invest; 2003 Aug; 50(3-4):146-53. PubMed ID: 13678383
[TBL] [Abstract][Full Text] [Related]
4. [Tumor inhibitory factors in urologic malignancies].
Uemura H
Hinyokika Kiyo; 2008 Jan; 54(1):49-52. PubMed ID: 18260361
[TBL] [Abstract][Full Text] [Related]
5. The role of vascular endothelial growth factor in kidney and prostate cancer.
Delongchamps NB; Peyromaure M
Can J Urol; 2007 Oct; 14(5):3669-77. PubMed ID: 17949520
[TBL] [Abstract][Full Text] [Related]
6. Bladder cancer angiogenesis and metastasis--translation from murine model to clinical trial.
Black PC; Dinney CP
Cancer Metastasis Rev; 2007 Dec; 26(3-4):623-34. PubMed ID: 17726580
[TBL] [Abstract][Full Text] [Related]
7. Targeting angiogenesis in head and neck cancer.
Seiwert TY; Cohen EE
Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis in urothelial tumors of the upper urinary tract.
Baderca F; Lighezan R; Dema A; Alexa A; Raica M
Rom J Morphol Embryol; 2005; 46(4):263-8. PubMed ID: 16688360
[TBL] [Abstract][Full Text] [Related]
9. Tumour-associated angiogenesis in human colorectal cancer.
Rmali KA; Puntis MC; Jiang WG
Colorectal Dis; 2007 Jan; 9(1):3-14. PubMed ID: 17181841
[TBL] [Abstract][Full Text] [Related]
10. Expression of survivin in gastric cancer and its relationship with tumor angiogenesis.
Lee GH; Joo YE; Koh YS; Chung IJ; Park YK; Lee JH; Kim HS; Choi SK; Rew JS; Park CS; Kim SJ
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):957-63. PubMed ID: 16894308
[TBL] [Abstract][Full Text] [Related]
11. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.
Gravdal K; Halvorsen OJ; Haukaas SA; Akslen LA
Cancer Res; 2009 Jun; 69(11):4708-15. PubMed ID: 19487287
[TBL] [Abstract][Full Text] [Related]
12. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
Ljungberg BJ; Jacobsen J; Rudolfsson SH; Lindh G; Grankvist K; Rasmuson T
BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769
[TBL] [Abstract][Full Text] [Related]
13. Chemo-angiogenic profile of bovine urinary bladder tumors distinguishes urothelial carcinomas from hemangiosarcomas.
Carvalho T; Elias AP; Nunes T; Peleteiro MC; Dias S
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):344-58. PubMed ID: 18022698
[TBL] [Abstract][Full Text] [Related]
14. Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radical cystectomy.
Beecken WD; Engl T; Jonas D; Blaheta RA
Int J Mol Med; 2009 Feb; 23(2):261-6. PubMed ID: 19148551
[TBL] [Abstract][Full Text] [Related]
15. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
16. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
Lee J; Wang A; Hu Q; Lu S; Dong Z
Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
[TBL] [Abstract][Full Text] [Related]
18. Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder.
Chikazawa M; Inoue K; Fukata S; Karashima T; Shuin T
Pathobiology; 2008; 75(6):335-45. PubMed ID: 19096229
[TBL] [Abstract][Full Text] [Related]
19. Microvessel density and angiogenic promoters in relation to metastatic urological carcinoma. Is there a difference between lymph node and more distant metastases subgroups?
Morgan DR; Gregg KL
Histopathology; 2002 Aug; 41(2):170-1. PubMed ID: 12147096
[No Abstract] [Full Text] [Related]
20. Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer.
Patel NS; Dobbie MS; Rochester M; Steers G; Poulsom R; Le Monnier K; Cranston DW; Li JL; Harris AL
Clin Cancer Res; 2006 Aug; 12(16):4836-44. PubMed ID: 16914569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
